Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α‐Amylase Inhibition Complemented With Computational Studies
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Neha Manhas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Durban University of Technology, Durban, South Africa. Hauptthemen laut MEDLINE: alpha-Amylases, Thiosemicarbazones, Hypoglycemic Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation, Durban University of Technology.
Abstract (Originalsprache)
The antidiabetic potential of a series of thiosemicarbazones was evaluated by examining their inhibitory activity α‐amylase, a key enzyme responsible for the hydrolysis of polysaccharides into simpler sugars through cleavage of internal α(1→4)‐glycosidic linkages. The results revealed several potent inhibitors, with the most active compound, 1‐(4‐(dimethylamino)benzylidene)thiosemicarbazide ( 6g ), exhibiting approximately two‐fold greater potency compared to the reference drug acarbose. Structure‐activity relationship analysis indicated that thiosemicarbazones derived from benzaldehydes and ketones ( 6a–6k , 7a–e ) contributed predominantly to the observed activity, outperforming analogues incorporating alternative pharmacophoric scaffolds such as isatin and furan ( 8a–b and 9a–d ). In addition to enzyme inhibition, several compounds demonstrated notable antioxidant activity across multiple in vitro assays, including nitric oxide (NO), DPPH radical scavenging, and ferric reducing antioxidant power (FRAP) assays. Molecular docking studies of representative compounds within the catalytic site of α‐amylase highlighted the critical role of hydrogen bonding and π‐π stacking interactions in stabilizing ligand‐enzyme complexes. Furthermore, in silico pharmacokinetic and drug‐likeness evaluations revealed that all synthesized compounds exhibited favorable profiles, in contrast to acarbose, which showed multiple violations of standard drug‐likeness criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Durban University of Technology, Durban, South Africa.
- Discipline of Chemistry, School of Agriculture and Science, University of KwaZulu-Natal, Durban, South Africa.
- Discipline of Biological Sciences, School of Agriculture and Science, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Gobind Kumar, Nagaraju Kerru, Almahi Idris, Md Shahidul Islam, Parvesh Singh
Förderung
- National Research Foundation
- Durban University of Technology
Zitieren
APA
Manhas, N., Kumar, G., Ankit, Kerru, N., Seboletswe, P., Gcabashe, N., Idris, A., Islam, M. S., Makhanya, T., & Singh, P. (2026). Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α‐Amylase Inhibition Complemented With Computational Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71362
Vancouver
Manhas N, Kumar G, Ankit, Kerru N, Seboletswe P, Gcabashe N, et al. Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α‐Amylase Inhibition Complemented With Computational Studies. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71362
BibTeX
@article{Manhas2026,
author = {Manhas, Neha and Kumar, Gobind and Ankit and Kerru, Nagaraju and Seboletswe, Pule and Gcabashe, Nontobeko and Idris, Almahi and Islam, Md Shahidul and Makhanya, Talent and Singh, Parvesh},
title = {Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α‐Amylase Inhibition Complemented With Computational Studies},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71362}
}
EUVIMED